HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Nanotechnology in Diabetes Treatment
Nanotechnology has aided the development of innovative glucose testing and insulin administration mechanisms in diabetes research, which have the potential to significantly improve diabetics' quality of life. Nanomaterials, nanostructures, nanoparticle design, and their uses in humans are all part of this topic. It also provides more precise information for diabetes mellitus diagnosis. Nanoparticles are being developed as contrast agents to aid in the early detection of type 1 diabetes, and numerous formulations have been evaluated in human clinical trials. In the hopes of developing a cure for type 1 diabetes, nanotechnology is being employed to assist engineers create more effective vaccines.
- Nanovaccines
- Nanosensors
- Nanomedicine
Committee Members
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Christian College of Medicine, Belize Diabetes 2025 Speakers
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Anil Harrison
Midwestern University, United States
Jun Dai
Des Moines University, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Christian College of Medicine, Belize
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : AI receptor binding studies reveal GPR146 conformational states across diabetic phenotypes: Analysis of C-peptide and insulin interactions in cholesterol metabolism, cortisol regulation, and the vitamin D-renin-angiotensin axis
David Petch, utR Biotech, Canada